Advances in Infectious Diseases, 2015, 5, 57-62
Published Online March 2015 in SciRes.
DHS ANALYTICAL STUDIES 62
Objectif du module : Identifier un triple emballage, définir les termes utilisés pour les emballages,classer les matières infectieuses et les exigences d'emballage correspondante
Le Cryopack 6.2/4L PSE est un conditionnement isotherme permettant l’expédition en température basse (réfrigération ou congélation) de matières infectieuses pour l’homme (matières identifiées dans la classe 6, division 6.2 des réglementations IATA, ADR et IMDG).
BMC Health Services Research (2017) 17:623 DOI 10.1186/s12913-017-2567-7
Research Article
Hindawi Publishing Corporation
AIDS Research and Treatment
Volume 2011, Article ID 621078, 7 pages doi:10.1155/2011/621078
Clinical Infectious Diseases
1586 - 1594 • CID 2016:62 (15 June) • HIV/AIDS
Avec une population estimée à 1 626 606 habitants et une densité de 16 habitants/km2, elle a pour chef-lieu Mbandaka qui est la plus grande ville. L'Équateur est depuis 2015 l’une des 26 provinces de la République démocratique du Congo (RDC).
Les localités de Wangata, Iboko et Bikoro son...t trois (03) des dix-huit (18) zones de santé (ZS) de cette province affectées par l’épidémie actuelle de la maladie à virus Ebola (MVE).
more
Final Draft narrative December 6, 2012 - This strategic plan, developed through the joint collaboration of all stakeholders in the different sectors is aimed at harnessing and bringing together all the stakeholders who have a role in the prevention, detection and management of epidemic and infectiou...s diseases in the country. The plan describes the common epidemic and infectious diseases, the measures that need to be undertaken to ensure their control, the key partners and their roles and sets out milestones to monitor progress.
more
MMWR: Recommendations and Reports / Vol. 62 / No. 9
Morbidity and Mortality Weekly Report
October 25, 2013
WHO has developed a clinical case definition of post COVID-19 condition by Delphi methodology that includes 12 domains, available for use in all settings. This first version was developed by patients, researchers and others, representing all WHO regions, with the understanding that the definition ma...y change as new evidence emerges and our understanding of the consequences of COVID-19 continues to evolve.
Post COVID-19 condition occurs in individuals with a history of probable or confirmed SARS CoV-2 infection, usually 3 months from the onset of COVID-19 with symptoms and that last for at least 2 months and cannot be explained by an alternative diagnosis. Common symptoms include fatigue, shortness of breath, cognitive dysfunction but also others and generally have an impact on everyday functioning. Symptoms may be new onset following initial recovery from an acute COVID-19 episode or persist from the initial illness. Symptoms may also fluctuate or relapse over time.
more
How has the pandemic impacted the fight against Polio? How has the polio infrastructure helped the fight against COVID-19? Why is it important that the world doesn’t take its eyes off polio? Sona Bari explains in Science in 5 this week.
WHO has developed a clinical case definition of post COVID-19 condition by Delphi methodology that includes 12 domains, available for use in all settings. This first version was developed by patients, researchers and others, representing all WHO regions, with the understanding that the definition ma...y change as new evidence emerges and our understanding of the consequences of COVID-19 continues to evolve.
Post COVID-19 condition occurs in individuals with a history of probable or confirmed SARS CoV-2 infection, usually 3 months from the onset of COVID-19 with symptoms and that last for at least 2 months and cannot be explained by an alternative diagnosis. Common symptoms include fatigue, shortness of breath, cognitive dysfunction but also others and generally have an impact on everyday functioning. Symptoms may be new onset following initial recovery from an acute COVID-19 episode or persist from the initial illness. Symptoms may also fluctuate or relapse over time.
more
The Asthma Control Questionnaire (ACQ) was developed to measure the primary goals of asthma management as identified by international guidelines. All guidelines indicate that to achieve good control, treatment should minimise day- and night-time symptoms, activity limitation, airway narrowing and re...scue bronchodilator use and thus reduce the risk of life-threatening exacerbations and long-term morbidity. Three independent studies have provided evidence that the ACQ is valid for measuring asthma control and has strong measurement properties for use both in clinical practice and research. In addition, the smallest change in score that can be considered clinically important has been determined.
more